Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevention of Heart Failure in Women: An Expert Consensus Statement on Sex-Specific Risk Factors.

European journal of heart failure·2026
Same author

Association Between Sleep Quality and Oxidative Stress in Postoperative Cardiovascular Patients-A Pilot Study.

Journal of sleep research·2026
Same author

Cardio-Obstetrics Care: Challenging Scenarios in Heart Failure and Future Directions.

European journal of heart failure·2026
Same author

Diagnostic Yield of Exome Sequencing in Patients With Congenital Heart Disease From Southern Africa.

Circulation. Genomic and precision medicine·2026
Same author

Heart Failure in Pregnancy: Where the 2025 ESC Guidelines "Cardiovascular disease and pregnancy" Illuminate-and Where Shadows Remain.

European journal of heart failure·2026
Same author

European Journal of Heart Failure International Expert Position Paper Utilisation, Optimisation, and Clinical Benefits of Steroidal Mineralocorticoid Receptor Antagonists in Heart Failure with a Reduced Ejection Fraction.

European journal of heart failure·2026
Same journal

Mitral valve anomalies in transposition of the great arteries.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same journal

Oncologic Safety of Omitting Mediastinal Lymph Node Dissection in Segmentectomy for Ground-Glass Opacity-Dominant Lung Cancer: A Supplementary Analysis of JCOG1211.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same journal

Progress in Thymic Malignancy Care: The Imperative for Global Standards and Collaboration.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same journal

Association between interventional cardiologist practice characteristics, CABG use, and clinical outcomes.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same journal

The EACTS Innovation Committee's Perspective on the "Heart Valve of the Future".

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same journal

Why Should the Current Generation of Surgical Residents be Academically Active-Lessons From the Past.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
See all related articles

Related Experiment Video

Updated: May 11, 2026

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.3K

Making a difference: 5 years of Cardiac Surgery Intersociety Alliance (CSIA).

R M Bolman1, P Zilla2, F Beyersdorf3

  • 1Division of Cardio-Thoracic Surgery, Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA.

European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|June 10, 2024
PubMed
Summary
This summary is machine-generated.

The Cardiac Surgery Intersociety Alliance (CSIA) established pilot programs in Mozambique and Rwanda to build sustainable cardiac surgery capacity. These initiatives have successfully increased case numbers and government commitment, improving access to care in developing nations.

Keywords:
Developing countriesSustainable cardiac surgery

More Related Videos

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.4K
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

712

Related Experiment Videos

Last Updated: May 11, 2026

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.3K
Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
09:12

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery

Published on: March 27, 2018

9.4K
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

712

Area of Science:

  • Global Health
  • Cardiovascular Surgery
  • Developing Economies

Background:

  • Significant unmet need for cardiac surgery in developing regions necessitates global collaboration.
  • The Cape Town Declaration highlighted disparities in access to cardiac surgical care.
  • The Cardiac Surgery Intersociety Alliance (CSIA) was formed to address this disparity.

Purpose of the Study:

  • To establish and evaluate sustainable, local cardiac surgical capacity in low-income countries.
  • To identify and support fledgling cardiac surgery programs through a needs assessment and proposal process.
  • To improve access to essential cardiac surgical procedures in underserved populations.

Main Methods:

  • Global needs assessment to identify prevalent pathologies, confirming rheumatic heart disease as a primary concern.
  • Selection of Mozambique and Rwanda as pilot sites based on government and institutional support.
  • Implementation of mentorship and training agreements, including virtual conferences and on-site support with a "assisting only" protocol.

Main Results:

  • Successful establishment of cardiac surgery programs in Mozambique and Rwanda over five years.
  • Demonstrated increase in case numbers, enhanced government commitment, and infrastructure upgrades in pilot sites.
  • CSIA's "Seal of Approval" facilitated industry donations and negotiations with global donors for further funding.

Conclusions:

  • The CSIA model effectively promotes sustainable cardiac surgery capacity building in developing countries.
  • International collaboration and targeted mentorship are crucial for improving cardiac surgical care access.
  • Expanding the CSIA Seal program can further strengthen global efforts in local cardiac surgery development.